Fundraising FoxAmed Ventures — 2023 Investments
3 investments dated 2023 · listed companies and verified rows first · show all
Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.
HardwareHealthtechMedical DevicesCampbell, US
Nitin Salunke(President & CEO)inJean Orth(Executive Officer)Mariam Maghribi(Executive Officer, Director)
BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)
Co-investors415 CapitalThe Capital PartnershipUnorthodox VenturesNovo HoldingsQatar Investment Authority
Sealonix develops hemostatic sealants based on proprietary biomaterials to control surgical bleeding, targeting surgeons and patients undergoing abdominopelvic and other surgical procedures.
BiotechMedical DevicesNew MaterialsBedford, US
Amarpreet Sawhney(Executive Officer, Director)Amar Sawhney(Founder)
Co-investorsExcelestar VenturesJ2 VenturesSparta GroupIyengar Capital Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.